Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Atis Nayci, E.S. Özgür, C. Özge, A. Ilvan (Mersin, Turkey). Relation of inflammatory process with COPD phenotype. Eur Respir J 2012; 40: Suppl. 56, 789

Member's Comments

No comment yet.

Related content which might interest you: Systemic inflammatory response in relation to disease severity and nutritional depletion in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 31s Year: 2004 Inflammatory phenotypes of COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015 Inflammatory cell microlocalisation and airway dysfunction: cause and effect? Source: Eur Respir J 2007; 30: 1043-1056 Year: 2007 A functional imaging study to investigate the relationship between pulmonary inflammation and systemic inflammation in COPD patients Source: International Congress 2016 – From microimaging to functional evaluation of the lung Year: 2016 Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 COPD, an inflammatory systemic disease. Inflammatory parameters in a group of COPD patients Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 The relationship between bronchial inflammation and markers of disease progression in COPD Source: Eur Respir J 2003; 22: Suppl. 45, 179s Year: 2003 Presence of progranulin in airway inflammation associated with COPD Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Features of systemic inflammation in patients with stable COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD? Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Relationship between monocyte-derived macrophage phagocytosis and airway inflammation in stable COPD Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Inflammatory phenotypes of severe exacerbation of COPD, a clinico-laboratory characterization. Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Nutritional and systemic inflammatory parameters in patients with COPD exacerbation: relation with functional parameters Source: Eur Respir J 2005; 26: Suppl. 49, 297s Year: 2005 Endothelial dysfunction and systemic inflammation in different COPD phenotypes Source: International Congress 2014 – COPD physiopathology Year: 2014 Relationship of monocyte-derived macrophage phagocytosis to exacerbation susceptibility in stable COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014